Stock Taper Revenue: Reported revenue for Q3 2025 was $1.6 million, a significant decline from $4.9 million in Q3 2024, primarily due to the divestiture of the light-duty business.
Cespira Performance: Cespira's revenue increased by 19% year-over-year to $19.3 million.
Adjusted EBITDA: Negative $5.9 million, worsening from negative $0.8 million in Q3 2024, driven by lower gross profit and increased operating expenditures.
Net Loss: Net loss from continuing operations was $10.4 million, compared to $6 million in the prior year, impacted by increased R&D and SG&A expenses, as well as foreign exchange losses.
Cash Position: Cash and cash equivalents stood at $33.1 million, with outstanding debt of $3.9 million.
The divestiture of the light-duty segment is seen as a key milestone in simplifying operations and focusing on core heavy-duty and alternative fuel systems.
The company is transitioning production lines from Italy to Canada and China, with expectations to begin production by year-end.
Cespira is expanding its market presence, recently adding a second OEM customer for HPDI components, which is expected to enhance revenue growth.
Westport is developing a new CNG solution aimed at the North American market, which will complement existing offerings and is set to undergo trials with demonstration fleets.
The company anticipates further cost reductions and operational efficiencies following the light-duty divestiture.
Westport aims to achieve volume growth in Cespira and expand into new geographies and OEM partnerships.
The company plans to reduce capital expenditures by 60% and SG&A expenses by 15% in 2026 to enhance shareholder value.
The significant drop in revenue and increased net loss indicate ongoing financial challenges, particularly as the company adjusts to its smaller operational scale.
Cespira's gross profit remains negative, highlighting the need for higher sales volumes to achieve profitability.
Foreign exchange losses and increased operating expenditures pose risks to financial stability.
The transition of manufacturing facilities may lead to temporary revenue declines as operations ramp up in new locations.
The CEO emphasized that the development cycle with new OEMs is typical and that feedback from trials is expected by mid-2025.
There is ongoing interest from multiple OEMs in HPDI technology, with the company no longer needing to prove the technology's viability.
Future capital contributions to the Cespira joint venture are anticipated as part of its three-year build-out plan.
The company is focused on establishing local manufacturing in China to enhance competitiveness and reduce geopolitical risks. Overall, while Westport is navigating significant challenges post-divestiture, it is positioning itself for future growth through strategic initiatives and operational efficiencies.
SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT